Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,797 papers from all fields of science
Search
Sign In
Create Free Account
DL 017
Known as:
DL-017
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Quinazolines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Effects of DL-017, a novel, potent and specific α1-Adrenoceptor antagonist on hypertension and hyperlipidemia in spontaneously hypertensive rats
Yen-Mei Lee
,
J. Chern
,
M. Yen
2002
Corpus ID: 79218210
The hypotensive effect of DL-017, a newly synthesized quinazoline derivative, was investigated in spontaneously hypertensive rats…
Expand
2001
2001
Blockade of alpha1-adrenoceptors and cardiac depressant effect by a newly synthetic antihypertensive drug, DL-017 of quinazoline derivative.
F. Ke
,
S. Yang
,
+6 authors
J. M. Yang
Chinese journal of physiology
2001
Corpus ID: 37821513
The electromechanical effects of 3-[[4-(2-methoxy phenyl)piperazin-1-yl]methyl]-5-(methylthio)-2,3-dihydroimidazo[1,2-c…
Expand
2001
2001
Blockade of alpha1-adrenoceptors and cardiac depressant effect by a newly synthetic antihypertensive drug, DL-017 of quinazoline derivative.
Kelly Fc
,
Yang Sn
,
+6 authors
Yang Jm
2001
Corpus ID: 196626967
1997
1997
Electrical and mechanical effects of a novel antihypertensive quinazoline derivative, 3-[[4-(2-methoxyphenyl) piperazin-1-ly]methyl]-5-(methylthio)-2,3-dihydroimidazo [1,2-c]quinazoline, on guinea…
J. M. Yang
,
T. C. Yuen
,
C. W. Chang
,
J. S. Jin
,
M. Yen
,
J. Chern
Journal of Cardiovascular Pharmacology
1997
Corpus ID: 25634543
Electrical and mechanical effects of 3-[[4-(2-methoxyphenyl)piperazin-1-ly]methyl]-5-(methylthio)-2,3-+ ++dihydroimidazo[1,2-c…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE